Xoma | XOMA - Srodki Pieniężne I Ekwiwalent

Cena Akcji
37.90
Dzienna Zmiana
0.01 0.03%
Miesięcznie
25.50%
Rocznie
57.00%
Q2 Prognozy TE
37.09




Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.23B 400M 2025-12
Agenus USD 3.46M 6.08M 2025-09
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Ardelyx USD 68M 25.28M 2025-12
aTyr Pharma USD 6.15M 11.07M 2025-09
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Celldex Therapeutics USD 28.87M 7.17M 2025-12
Curis USD 10.14M 10.14M 2025-06
Eli Lilly USD 7.27B 2.52B 2025-12
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Incyte USD 3.58B 650.78M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Prothena USD 307.53M 23.31M 2025-12
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Xoma USD 143.9M 7.68M 2024-06